Navigation Links
In Turkey, the Use of Targeted Therapies Will Continue to Sustain the Colorectal Cancer Drug Market
Date:9/25/2013

BURLINGTON, Mass., Sept. 25, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that, from 2012 to 2017, the colorectal cancer (CRC) market in Turkey will grow at an annual rate of four percent, reaching $90 million in 2017. The Emerging Markets report entitled Colorectal Cancer in Turkey finds that the rapidly growing CRC patient population, the launches of several new branded therapies, and the continued use of branded agents, in particular targeted therapies, Roche's Avastin (Altuzan in Turkey) and Merck's Erbitux, will drive growth in this market.

Between 2012 and 2017, five branded CRC therapies will launch in Turkey, namely Amgen's Vectibix (launched in Turkey in May 2013), Bayer's Stivarga, Sanofi's Zaltrap, Alchemia's HA-irinotecan and Eli Lilly's ramucirumab. As a result of current therapies being well entrenched in the market, new therapies will provide some competition to the existing agents but will not substantially diminish their patient shares—new therapies will together contribute 11 percent to the total CRC market in 2017.

The report also finds that the number of incident cases of CRC in Turkey will almost double between 2012 and 2022, mainly due to an increase in disease risk, but also because of growing and aging population.

"Turkish oncologists frequently use targeted therapies when treating their metastatic CRC patients and interviewed experts report that all of their metastatic patients undergo KRAS testing–this is more in line with the medical practice of the major markets than of some other emerging markets that we cover," said Decision Resources Analys
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. K94 Discoveries, Inc. Announces Seed Financing To Advance Targeted Drug Conjugates To Treat Pancreatic And Other Cancers
2. New Drug that Delivers Targeted Radiation Minimizes Pain and May Extend Prostate Cancer Survival
3. MultiCell Technologies and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer
4. Protein Targeted For Cancer Drug Development Is Essential For Normal Heart Function
5. Emerging Targeted Therapies Offer Efficacy Advantages Over Currently Used Chemotherapies for Platinum-Resistant Advanced Ovarian Cancer
6. Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia
7. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
8. MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of Noncoding Micro RNAs for the Treatment of Liver Cancer
9. Algeta and Lumiphore Announce Further Expansion of Their Global Partnership for the Development of Targeted Alpha-pharmaceutical Cancer Therapeutics and Companion Diagnostics.
10. ADial Pharmaceuticals Announces Agreement With FDA For Phase III Trial Of AD04 For Alcohol Use Disorder In Patients Of Targeted Genotypes
11. KaloBios Targeted Antibacterial KB001-A to be Featured in BIO 2013 Panel Discussion of "New Defenses Against Old Enemies"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... N.C. , May 22, 2015  Research ... hosting its sixth Medical Affairs Roundtable ... (EDT) via a virtual roundtable to discuss "Medical ... Best Practices, Medical Affairs Consortium provides ... insights about the key challenges they face. The ...
(Date:5/22/2015)... May 22 2015 /CNW/ - The Taskforce representing ... of all the hard work that the Minister and Health ... months. This program recognizes the needs of the thalidomide survivors, ... $75,000 a year, tax free, with annual adjustments for inflation. ... for annual payments of $100,000 based on the severity of ...
(Date:5/22/2015)... , May 22, 2015  Amgen ... Company has commenced termination of its participation ... with AstraZeneca (LON:AZN, STO:AZN and NYSE: ... is in development for patients with moderate-to-severe ... The decision was based on events of ...
Breaking Medicine Technology:Best Practices Sixth Medical Affairs Consortium Roundtable to Focus on Health Economics & Outcomes Research 2Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5
... The U.S. Food and Drug Administration today issued new ... needle-free clinical devices to administer influenza vaccinations. Based on ... ) immediately discontinued use of such clinical devices at ... The Kroger family of pharmacies and The Little ...
... HAYWARD, Calif., Oct. 21, 2011 Intarcia ... a letter of intent with Quintiles , the world,s ... 3 program for Intarcia,s ITCA 650 (DUROS® subcutaneous continuous delivery ... GLP-1 therapy to better address the unmet needs of the ...
Cached Medicine Technology:Intarcia and Quintiles Sign Letter of Intent for Innovative Global Collaboration to Advance ITCA 650 in Type 2 Diabetes 2Intarcia and Quintiles Sign Letter of Intent for Innovative Global Collaboration to Advance ITCA 650 in Type 2 Diabetes 3Intarcia and Quintiles Sign Letter of Intent for Innovative Global Collaboration to Advance ITCA 650 in Type 2 Diabetes 4
(Date:5/23/2015)... May 23, 2015 On May 16, the ... The event was a 5k mud obstacle run that raised ... 2 million people worldwide, and the reason we participated was ... Chad Davis, owner of Farrell’s eXtreme Bodyshaping. “One-hundred percent of ... Society.” , The event was not only attended by eXtreme ...
(Date:5/23/2015)... MD (PRWEB) May 23, 2015 Injury lawyer ... that has been passed by the Maryland legislature but which ... “The Maryland General Assembly passed HB 449 with ... Governor has not signed it into law. This bill ensures ... Evidence is growing that demonstrates the danger of fracking to ...
(Date:5/22/2015)... 2015 River Valley Health Partners (RVHP) ... health system’s Chief Financial Officer (CFO), will be leaving ... as the company CFO since 2011. , The Board ... the health system as CFO. Wesley will oversee the ... the Board of Trustees conducts a formal search for ...
(Date:5/22/2015)... Hands On HealthCare Massage Therapy and ... Annual One Day Sale on Massage and Facial ... offers drastically reduced certificates one day a year. This sale ... through what used to be the slowest time of the ... as well. This once a year occurrence has become a ...
(Date:5/22/2015)... Memorial Day weekend is typically considered the beginning of ... tips to help promote safe travel. , According to estimates ... fatalities this Memorial Day weekend. Amica is sharing the following ... , , Always wear a seatbelt: ... whether they’re driving or riding along as a passenger. Seatbelts ...
Breaking Medicine News(10 mins):Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 3Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 3Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2
... , WASHINGTON, Nov. 17 Family Research ... Congressional leaders to repudiate comments made by U.S. Rep. Diana DeGette ... be shut out of the process" in the health care debate ... told The Hill , "Last I heard, we had separation ...
... , ORLANDO, Fla., Nov. 17 ... concerning a drug interaction between clopidogrel, an anti-clotting medication, and ... acid. , The FDA notes that they have new data ... was less effective in its anti-clotting action than when given ...
... a losing battle with a triple-chocolate cake, a "mental budget" ... Journal of Consumer Research . "There are some ... so," write authors Parthasarathy Krishnamurthy (University of Houston) and Sonja ... curtail consumption of sugars and fat, one ends up consuming ...
... and not an ill of the modern world , TUESDAY, ... have more of a family history -- the human family ... have unearthed hardening of the arteries -- or atherosclerosis, which ... 3,500 years old. , Experts have long believed that atherosclerosis ...
... , NEW ... new market research report is available in its ... Products - A US and European Market Review ... , The obsession of Americans to look young ...
... CLEVELAND--Hospice workers have watched patients emerge from comas and cling ... forgive them. This phenomenon of taking care of unfinished ... Bolton School of Nursing and the College of Arts and ... to understand what drives the dying to live long enough ...
Cached Medicine News:Health News:FRC Calls on President Obama, Speaker Pelosi, and Senator Reid to Repudiate Diana DeGette's Religious Bigotry 2Health News:American College of Cardiology/American Heart Association Comment on the FDA Public Health Advisory Regarding a Drug Interaction Between Clopidogrel and Omeprazole 2Health News:To eat or not to eat? Mental budgets help control consumption 2Health News:The Mummies' Curse: Heart Disease 2Health News:The Mummies' Curse: Heart Disease 3Health News:Reportlinker Adds Cosmetic Surgery Procedures and Products - A US and European Market Review 2Health News:Reportlinker Adds Cosmetic Surgery Procedures and Products - A US and European Market Review 3Health News:Reportlinker Adds Cosmetic Surgery Procedures and Products - A US and European Market Review 4Health News:Reportlinker Adds Cosmetic Surgery Procedures and Products - A US and European Market Review 5Health News:Reportlinker Adds Cosmetic Surgery Procedures and Products - A US and European Market Review 6Health News:Reportlinker Adds Cosmetic Surgery Procedures and Products - A US and European Market Review 7Health News:Reportlinker Adds Cosmetic Surgery Procedures and Products - A US and European Market Review 8Health News:Reportlinker Adds Cosmetic Surgery Procedures and Products - A US and European Market Review 9Health News:Reportlinker Adds Cosmetic Surgery Procedures and Products - A US and European Market Review 10Health News:Researchers focus on helping dying patients take care of unfinished business 2Health News:Researchers focus on helping dying patients take care of unfinished business 3
The SE-9000 automated hematology analyzer provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test results for enhanced screening ability....
The XE-2100 automated hematology analyzer features new hematology parameters as NRBC, IRF, and HPC that offer valuable and accurate clinical information....
... The CKX microscopes utilize the infinity-corrected optical ... cell checking. Olympus has taken this one ... modular design approach with the capability of ... images with digital imaging and video monitoring. ...
... The CX31 continue the ... the CH2 microscopes in ... now with UIS infinity-corrected ... improve all-around performance and ...
Medicine Products: